Regulatory Approvals

Acute brain failure costs the US healthcare system $164 billion annually1 – rivaling the cost of care for heart disease and diabetes2 DeltaScan is the world's first bedside...

TytoCare receives FDA 510(k) for wheeze detection software Virtual primary care company TytoCare received FDA 510(k) clearance for clinical decision support software that analyzes lung sounds for...

Pivotal study expected to be completed by year-end 2023 and set the stage for commercialization of PerQseal® system for large hole vessel closure Company announces €30...

Singaporean startup Respiree gets US FDA 510(k) for respiration monitor Respiree, a med tech spinoff of Singapore's Agency for Science, Technology and Research, has obtained...

LivaNova (Nasdaq:LIVN) announced that it received FDA 510(k) clearance for its Essenz heart-lung machine (HLM). With clearance, the London-based company initiated its U.S. commercial launch...

The approval marks its entry into the $160-billion US medical device market. South Korean medtech firm Coreline Soft has obtained the United States Food and Drug Administration's...

Neuromod Device’s treatment is first of its kind signed off by US regulators A tinnitus treatment developed by Irish company Neuromod Devices has been granted...

Nyxoah Announces Achievement of Key Clinical and Regulatory MilestonesAll 115 patients implanted in DREAM U.S. pivotal studyFirst DREAM PMA module submittedFirst patient implanted in...

Noah Medical announced that it received FDA clearance for its Galaxy System for robotic-navigated bronchoscopy. San Carlos, California-based Noah Medical designed Galaxy and its accessories to...